Antiproteinuric therapy decreases LDL-cholesterol as well as HDL-cholesterol in non-diabetic proteinuric patients: relationships with cholesteryl ester transfer protein mass and adiponectin-Reference-Cited by-同舟云学术

Antiproteinuric therapy decreases LDL-cholesterol as well as HDL-cholesterol in non-diabetic proteinuric patients: relationships with cholesteryl ester transfer protein mass and adiponectin

Published:2009-04-27 Issue:5 Volume:13 Page:497-504
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Krikken JA,Waanders F,Dallinga-Thie GM,Dikkeschei LD,Vogt L,Navis GJ,Dullaart RPF

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728220902905865

Reference29 articles.

1. The increased risk of coronary heart disease associated with nephrotic syndrome

2. Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction

3. Abnormalities of Lipoprotein Metabolism in Patients with the Nephrotic Syndrome

4. The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuria

5. Lipid abnormalities in renal disease

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease;Cochrane Database of Systematic Reviews;2023-07-19

2. Dyslipidemia in Chronic Kidney Disease;Evidence‐Based Nephrology;2022-11-18

3. Altered dietary salt intake for people with chronic kidney disease;Cochrane Database of Systematic Reviews;2021-06-24

4. Association of apoE gene polymorphisms with lipid metabolism in renal diseases;African Health Sciences;2020-10-07

5. Progress of research on dyslipidemia accompanied by nephrotic syndrome;Chronic Diseases and Translational Medicine;2020-09